Authors:
TOBI M
CHINTALAPANI S
HATFIELD J
GALAGAN K
KOZAREK R
INAGAKI M
KASAI S
TOKUSASHI Y
ADSAY V
HRUBAN R
LOUGH J
BARKUN A
JABBARI M
DUGUID W
FLIGIEL S
Citation: M. Tobi et al., A COMPARISON OF ADNAB-9 STAINING IN INTRADUCTAL PAPILLARY MUCIN-PRODUCING NEOPLASIA (IPMN) AND COMMON PANCREATIC ADENOCARCINOMA, Gastroenterology, 112(4), 1997, pp. 669-669
Authors:
TOBI M
CHINTALAPANI S
HATFIELD J
FLIGIEL S
GALAGAN KA
KOZAREK R
Citation: M. Tobi et al., PANCREATICOBILIARY TRACT NEOPLASIA WHICH PROCEEDS THROUGH AN IDENTIFIABLE PREMALIGNANT LESION MAY BE AMENDABLE TO EARLY DIAGNOSIS USING A PREMALIGNANT MARKER, Hepatology, 23(1), 1996, pp. 255-255
Authors:
TOBI M
CHINTALAPANI S
GOO R
MALIAKKAL B
REDDY J
LUNDQVIST M
OBERG K
LUK G
Citation: M. Tobi et al., OMEPRAZOLE INHIBITS GROWTH OF CANCER CELL-LINE OF COLONIC ORIGIN, Digestive diseases and sciences, 40(7), 1995, pp. 1526-1530
Authors:
TOBI M
CHINTALAPANI S
WEAVER D
ABBRUZZESE J
HATFIELD J
DEMATTIA F
SHEAHAN D
FLIGIEL S
Citation: M. Tobi et al., PROSPECTIVE DIAGNOSIS OF MUCINOUS VILLOUS ADENOMATOSIS OF THE PANCREATICOBILIARY SYSTEM BY ADNAB-9 MONOCLONAL-ANTIBODY, Gastroenterology, 108(4), 1995, pp. 546-546
Authors:
CATS A
KLEIBEUKER JH
CHINTALAPANI S
TOBI M
Citation: A. Cats et al., A PREMALIGNANT MARKER FOR ADENOMA-CARCINOMA CARCINOGENESIS SHOWS INCREASED EXPRESSION IN HEREDITARY NONPOLYPOSIS COLON-CANCER (HNPCC) PATIENTS, Gastroenterology, 106(4), 1994, pp. 10000376-10000376